Transfusion Medicine Chapter Quiz
41 Questions
0 Views

Transfusion Medicine Chapter Quiz

Created by
@FastMars

Questions and Answers

What is the most critical step in preventing acute hemolytic transfusion reactions?

  • Adhering to hemoglobin target levels in restrictive transfusion
  • Performing infectious disease testing on donors
  • Accurate identification of the pretransfusion blood sample and recipient (correct)
  • Establishing venous access before transfusion
  • Which blood donor criteria must be met according to FDA regulations?

  • Donors must meet specific infectious disease testing criteria (correct)
  • Donors should only be under the age of 35
  • Donors can be accepted regardless of medical history
  • Blood components must be licensed for interstate distribution
  • What is the target hemoglobin level associated with restrictive red cell transfusions?

  • 9–10 g/dL
  • 7–8 g/dL (correct)
  • 6–7 g/dL
  • 8–9 g/dL
  • For which condition is platelet transfusion generally indicated?

    <p>Microvascular bleeding with a platelet count of 15% of estimated blood volume</p> Signup and view all the answers

    What must blood centers do if they manufacture blood components?

    <p>Obtain a license for distribution in interstate commerce</p> Signup and view all the answers

    What is the minimum acceptable platelet count for transfusion indicated in the context provided?

    <p>15% of estimated blood volume</p> Signup and view all the answers

    What does the performance of pretransfusion testing include?

    <p>Choosing the appropriate blood type for the patient</p> Signup and view all the answers

    What is a common misconception regarding hemoglobin targets in blood transfusion?

    <p>Higher hemoglobin levels are always better</p> Signup and view all the answers

    Why is it essential to establish venous access before a blood transfusion?

    <p>To ensure the rapid administration of blood in emergencies</p> Signup and view all the answers

    What complication is characterized by fever and chills during or after a transfusion?

    <p>Febrile Nonhemolytic Reactions</p> Signup and view all the answers

    Which component is specifically manufactured for patients requiring factor replacement therapy?

    <p>Cryoprecipitated Antihemophilic Factor</p> Signup and view all the answers

    What type of reaction occurs when a patient experiences hypotension during transfusion due to fluid overload?

    <p>Transfusion-Associated Circulatory Overload</p> Signup and view all the answers

    What is the primary purpose of leukocyte-reduction in blood components?

    <p>To prevent febrile nonhemolytic reactions</p> Signup and view all the answers

    Which pathogen reduction method is used to eliminate infectious agents in blood components?

    <p>Ultraviolet Light Irradiation</p> Signup and view all the answers

    Which transfusion reaction may occur due to the presence of donor antibodies reacting with recipient leukocytes?

    <p>Graft-Versus-Host Disease</p> Signup and view all the answers

    What is one of the primary purposes of leukocyte reduction in blood components?

    <p>To prevent transfusion-associated acute lung injury</p> Signup and view all the answers

    What is the main function of transfusion services described in transfusion medicine?

    <p>Issuing blood components and providing medical support</p> Signup and view all the answers

    What does pathogen reduction primarily aim to achieve in transfusion medicine?

    <p>Reduce risks of transfusion-transmitted infections</p> Signup and view all the answers

    Which type of medical issue can be prevented by irradiating blood components?

    <p>Graft-versus-host disease</p> Signup and view all the answers

    Why is establishing venous access prior to a blood transfusion important?

    <p>To ensure immediate reaction to any adverse effects.</p> Signup and view all the answers

    What is the significance of a platelet count being less than 15% of estimated blood volume?

    <p>It is a threshold for considering platelet transfusion.</p> Signup and view all the answers

    What is the association between restrictive red cell transfusion and patient outcomes?

    <p>Improved outcomes in some patient populations</p> Signup and view all the answers

    Which method can increase the number of circulating hematopoietic progenitor cells (HPCs)?

    <p>Growth factor stimulation</p> Signup and view all the answers

    What is the primary reason for using leukocyte-reduced blood components?

    <p>To prevent immunization to HLA antigens</p> Signup and view all the answers

    What is the maximum allowable number of residual leukocytes in leukocyte-reduced whole blood-derived platelet concentrates?

    <p>8.3 × 10^5</p> Signup and view all the answers

    What is a possible adverse effect caused by leukocytes in blood components?

    <p>Febrile nonhemolytic transfusion reactions</p> Signup and view all the answers

    What is a key advantage of prestorage leukocyte reduction over poststorage?

    <p>It can prevent the accumulation of cytokines.</p> Signup and view all the answers

    What must be done to hematopoietic progenitor cells (HPCs) for long-term storage?

    <p>Frozen with a cryoprotective agent</p> Signup and view all the answers

    Which factor has not conclusively shown to prevent posttransfusion graft-versus-host disease?

    <p>Leukocyte reduction</p> Signup and view all the answers

    What complication can result from using blood from donors with sickle trait during leukocyte reduction?

    <p>Filtration failures due to Hb S polymerization</p> Signup and view all the answers

    Which cells can be used for donor lymphocyte infusion in the graft-versus-tumor effect?

    <p>Mononuclear cells</p> Signup and view all the answers

    What is one of the primary components found in cryoprecipitate?

    <p>Factor VIII</p> Signup and view all the answers

    What percentage range of fibrinogen is typically retained in cryoprecipitate after plasma thawing?

    <p>20% to 40%</p> Signup and view all the answers

    Why is cryoprecipitate significant in transfusion medicine?

    <p>It was an essential advance in hemophilia A treatment.</p> Signup and view all the answers

    What is the FDA requirement for the amount of factor VIII in a unit of cryoprecipitate?

    <p>80 IU</p> Signup and view all the answers

    What is the primary usage of cryoprecipitated antihemophilic factor today?

    <p>Mainly as a source of fibrinogen</p> Signup and view all the answers

    What is the optimal storage temperature for liquid plasma to maintain its availability for transfusion?

    <p>2°C to 6°C</p> Signup and view all the answers

    What is a major disadvantage of liquid plasma compared to other plasma products?

    <p>Coagulation factors become less concentrated after 7 days of storage.</p> Signup and view all the answers

    For which specific medical situation is liquid plasma indicated according to the provided information?

    <p>Trauma resuscitation</p> Signup and view all the answers

    What is a significant limitation of using liquid plasma stored for more than 7 days?

    <p>The labile coagulation factors decrease in concentration.</p> Signup and view all the answers

    How does liquid plasma's storage requirement impact its role during medical emergencies?

    <p>It is immediately available without thawing.</p> Signup and view all the answers

    Study Notes

    Background of Transfusion Medicine

    • Transfusion medicine covers blood donation, component preparation, serology, and transfusion therapy.
    • The term "blood banking" has evolved into "transfusion medicine" to highlight patient care and clinical outcomes.

    Blood Donor Eligibility and Regulations

    • Blood donor criteria are set by the FDA to safeguard both donors and transfusion recipients.
    • All blood establishments, including blood centers and transfusion services, must be FDA-registered and licensed for interstate commerce.

    Blood Component Manufacturing

    • Major blood components include red blood cells, platelet concentrates, fresh frozen plasma, and cryoprecipitate.
    • Components are manufactured and stored to minimize functional loss and maximize patient outcomes.
    • Key techniques in blood manufacturing include leukocyte reduction and pathogen reduction to decrease transmission risks.

    Blood Collection and Distribution

    • Blood centers are responsible for recruiting donors, collecting blood, and distributing components to transfusion services.
    • Transfusion services conduct compatibility testing and provide medical support but do not typically collect blood.

    Transfusion Guidelines and Recommendations

    • Restrictive red cell transfusion is recommended for certain patients with a hemoglobin target of 7–8 g/dL to improve outcomes.
    • Platelet transfusions are indicated for microvascular bleeding when platelet counts are critically low.

    Pretransfusion Testing and Administration

    • Accurate identification of blood samples and recipients is crucial to prevent acute hemolytic reactions.
    • Blood component administration is highly regulated and must follow strict protocols to ensure safety.

    Transfusion Reactions

    • Types of transfusion reactions include:
      • Acute Hemolytic Reactions: Immediate response, often due to ABO incompatibility.
      • Delayed Hemolytic Reactions: Occur days to weeks after transfusion, related to minor antigen discrepancies.
      • Febrile Nonhemolytic Reactions: Common and usually benign, characterized by fever.
      • Allergic Reactions: Can range from mild to severe (anaphylaxis).
      • Transfusion-Related Acute Lung Injury: A serious, though rare, complication of transfusion.
      • Transfusion-Associated Circulatory Overload: May occur with rapid or large volume transfusions.

    Specialized Practices

    • Graft-versus-host disease prevention through irradiation of blood components.
    • Leukocyte reduction decreases risks associated with human leukocyte antigens and infections like cytomegalovirus.

    Conclusion

    • Transfusion medicine is a critical field aimed at optimizing blood transfusion safety and effectiveness while minimizing risks to patients and donors alike.

    Background of Transfusion Medicine

    • Transfusion medicine covers blood donation, component preparation, serology, and transfusion therapy.
    • The term "blood banking" has evolved into "transfusion medicine" to highlight patient care and clinical outcomes.

    Blood Donor Eligibility and Regulations

    • Blood donor criteria are set by the FDA to safeguard both donors and transfusion recipients.
    • All blood establishments, including blood centers and transfusion services, must be FDA-registered and licensed for interstate commerce.

    Blood Component Manufacturing

    • Major blood components include red blood cells, platelet concentrates, fresh frozen plasma, and cryoprecipitate.
    • Components are manufactured and stored to minimize functional loss and maximize patient outcomes.
    • Key techniques in blood manufacturing include leukocyte reduction and pathogen reduction to decrease transmission risks.

    Blood Collection and Distribution

    • Blood centers are responsible for recruiting donors, collecting blood, and distributing components to transfusion services.
    • Transfusion services conduct compatibility testing and provide medical support but do not typically collect blood.

    Transfusion Guidelines and Recommendations

    • Restrictive red cell transfusion is recommended for certain patients with a hemoglobin target of 7–8 g/dL to improve outcomes.
    • Platelet transfusions are indicated for microvascular bleeding when platelet counts are critically low.

    Pretransfusion Testing and Administration

    • Accurate identification of blood samples and recipients is crucial to prevent acute hemolytic reactions.
    • Blood component administration is highly regulated and must follow strict protocols to ensure safety.

    Transfusion Reactions

    • Types of transfusion reactions include:
      • Acute Hemolytic Reactions: Immediate response, often due to ABO incompatibility.
      • Delayed Hemolytic Reactions: Occur days to weeks after transfusion, related to minor antigen discrepancies.
      • Febrile Nonhemolytic Reactions: Common and usually benign, characterized by fever.
      • Allergic Reactions: Can range from mild to severe (anaphylaxis).
      • Transfusion-Related Acute Lung Injury: A serious, though rare, complication of transfusion.
      • Transfusion-Associated Circulatory Overload: May occur with rapid or large volume transfusions.

    Specialized Practices

    • Graft-versus-host disease prevention through irradiation of blood components.
    • Leukocyte reduction decreases risks associated with human leukocyte antigens and infections like cytomegalovirus.

    Conclusion

    • Transfusion medicine is a critical field aimed at optimizing blood transfusion safety and effectiveness while minimizing risks to patients and donors alike.

    Transfusion Medicine Overview

    • Transfusion medicine integrates blood donation, component preparation, serology, and transfusion therapy, focusing on patient care and clinical outcomes.
    • Blood banking terminology has evolved to emphasize transfusion medicine's broader scope.

    Blood Component Sources and Functions

    • Blood components include red blood cells, platelet concentrates, fresh frozen plasma, and cryoprecipitate.
    • Leukocyte reduction helps in reducing alloimmunization and the risk of febrile reactions and cytomegalovirus transmission.
    • Irradiation of blood components is critical in preventing graft-versus-host disease.
    • Pathogen reduction techniques significantly lower the risk of transfusion-transmitted infections.

    Blood Donation and Collection

    • Blood centers are responsible for recruiting donors, collecting blood, and manufacturing blood components.
    • Most hospital transfusion services rely on regional blood centers for access to blood components, rather than collecting their own.
    • All blood establishments must be registered with the FDA and adhere to strict standards regarding donor eligibility and blood component manufacturing.

    Pretransfusion Testing and Compatibility

    • Accurate identification of pretransfusion blood samples and recipients is vital to prevent acute hemolytic transfusion reactions.
    • Pretransfusion compatibility testing is conducted to ensure safe transfusions.

    Blood Transfusion Guidelines

    • Restrictive red cell transfusion practices, targeting hemoglobin levels of 7-8 g/dL, have demonstrated improved outcomes in specific patient groups.
    • Platelet transfusions are indicated for microvascular bleeding and when platelet counts are critically low.

    Adverse Reactions to Transfusion

    • Various transfusion reactions include acute and delayed hemolytic reactions, febrile nonhemolytic reactions, allergic reactions, and anaphylactic reactions.
    • Awareness of risks like bacterial contamination, transfusion-related acute lung injury, and transfusion-associated circulatory overload is crucial for patient safety.

    Conclusion Notes

    • The regulation and operational aspects of blood centers and transfusion services underscore the emphasis on safety and quality in transfusion medicine.

    Plasma and Fresh Frozen Plasma (FFP)

    • Plasma is extracted from whole blood and frozen for long-term storage.
    • Freezing plasma at approximately −18°C preserves its quality, especially for clotting factors.
    • FFP must be frozen within 8 hours of collection to maintain its effectiveness.
    • Plasma labels vary based on the time and conditions before freezing:
      • PF24 if held at 4°C for up to 24 hours.
      • PF24RT24 if held at room temperature.
    • FFP and its equivalents (PF24, PF24RT24) have similar coagulation factor content.
    • Frozen plasma can be stored for up to 1 year at −18°C.
    • Thawed plasma must be transfused within 24 hours and can be kept at fridge temperatures for up to 5 days.

    Cryoprecipitated Antihemophilic Factor

    • Cryoprecipitate is the insoluble component obtained after thawing FFP.
    • Contains about 50% factor VIII, 20-40% fibrinogen, von Willebrand factor (vWF), and factor XIII.
    • At least 80 IU of factor VIII is required per unit according to FDA regulations.
    • Usually contains around 250 mg of fibrinogen.
    • Primarily utilized for fibrinogen source today; historically used to treat hemophilia A.

    Platelet Concentrates (PCs)

    • PCs are derived from whole blood via centrifugation, leaving platelet-rich plasma.
    • Must contain at least 5.5 × 10^10 platelets and stored at 20-24°C to maintain viability.
    • FDA allows up to 5 days of storage with continuous agitation to prevent clumping.
    • Alkalinity (pH) must remain 6.0 or above at the end of storage.
    • Pools of PCs are required to achieve therapeutic doses (3.0 × 10^11 platelets) for adults.
    • Pooled PCs that utilize open systems must be transfused within 4 hours.
    • Apheresis platelets (single donation) also serve as an alternative source, collecting higher platelets in one session.

    Leukocyte Components

    • Granulocytes can be collected via apheresis and stored for up to 24 hours at room temperature.
    • They require immediate transfusion for effective treatment due to decreased functionality over time.
    • Donor stimulation with G-CSF is often necessary to obtain sufficient granulocyte volumes.
    • Mononuclear cells can provide hematopoietic progenitor cells (HPCs) for transplantation.
    • HPCs can be frozen with cryoprotective agents and thawed for use post-collection.

    Leukocyte-Reduced Blood Components

    • Reduction of leukocytes in RBCs and PCs minimizes transfusion complications, including febrile reactions and graft-versus-host disease.
    • Universal leukocyte reduction is practiced but does not conclusively prevent all adverse effects.
    • Blood components must have fewer than 5 × 10^6 residual leukocytes for RBCs and fewer than 8.3 × 10^5 for PCs.
    • Prestorage leukocyte reduction prevents the accumulation of harmful biological modifiers, improving safety.
    • Specific filtration devices can effectively prepare components with reduced leukocyte counts.
    • Failures may occur during filtration from donors with sickle cell trait due to low oxygen tension impacts on Hb S polymerization.
    • Granulocytes and HPCs cannot undergo leukocyte reduction.

    Cryoprecipitated Antihemophilic Factor (Cryoprecipitate or Cryo)

    • Cryoprecipitate is the cold insoluble portion obtained from thawed Fresh Frozen Plasma (FFP).
    • Contains approximately 50% of factor VIII, essential for blood clotting.
    • Comprises 20% to 40% of the original plasma unit's fibrinogen, crucial for clot formation.
    • Also includes von Willebrand factor (vWF), involved in platelet adhesion.
    • Contains factor XIII, which stabilizes blood clots.
    • FDA mandates a minimum of 80 IU of factor VIII per unit of cryoprecipitate, although many centers provide higher levels.
    • A single unit of cryoprecipitate typically has about 250 mg of fibrinogen, but content testing is not obligatory.
    • Significantly advanced hemophilia A treatment before the advent of purified clotting factor concentrates.
    • Currently used primarily as a source of fibrinogen in clinical settings.

    Liquid Plasma Overview

    • Liquid plasma is derived from whole-blood donations and is not subjected to freezing.
    • It is stored at temperatures between 2°C to 6°C for a period of up to 5 days after the whole-blood expiration date.

    Advantages of Liquid Plasma

    • Readily available for transfusion during trauma cases due to the absence of thawing requirements.
    • This immediate availability can be crucial in emergency situations.

    Disadvantages of Liquid Plasma

    • Coagulation factors that are sensitive to storage temperatures (2°C to 6°C) may reduce in concentration after 7 days of storage.
    • Due to reduced coagulation factor levels, liquid plasma is specifically indicated for trauma resuscitation and not for other medical uses.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on transfusion medicine with this quiz based on the chapter by Elkins, Davenport, and Mintz. Explore crucial topics such as blood collection, component selection, and potential reactions during transfusions. Perfect for students and professionals in the medical field!

    Use Quizgecko on...
    Browser
    Browser